(Alliance News) - IXICO PLC said Thursday Chief Financial Officer Grant Nash has joined the board of the neuroscience-focused data analytics firm, whilst Non-Executive Director Tim Sharpington to Read More
(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------J up 3.8%. The is Read More
(Alliance News) - IXICO PLC on Monday said it anticipates annual results to be "materially" ahead of current market expectations.Shares in IXICO were trading 27% higher on Monday Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - Group, up 2.5%. The equipment rentals firm said Read More
LONDON (Alliance News) - IXICO PLC said Tuesday it inked a new contract worth GBP9.1 million with an unnamed "top-10 global pharmaceutical company".Shares in the data analysis up Read More
LONDON (Alliance News) - Data science company IXICO PLC said on Monday it has proposed to reorganise its share capital through a share consolidation and sub-division, subject to shareholder reason Read More
LONDON (Alliance News) - Data science company IXICO PLC said Thursday it has extended its contract with an undisclosed biopharmaceutical company, raising its total value to EUR1.3 deal between and Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 1.3%. The housebuilder said it continued to Read More
LONDON (Alliance News) - Shares in IXICO PLC rose on Tuesday as the company said it expects 24% jump in annual revenue, ahead of market expectations.IXICO shares were trading up 16% at the Read More
LONDON (Alliance News) - IXICO PLC said Monday it signed an expansion to an existing trial study contract with an unnamed pharmaceutical company, worth GBP600,000.The additional services to Read More
LONDON (Alliance News) - AstraZeneca PLC said Tuesday it has decided to discontinue trials of a new drug for Alzheimer's disease as the treatment is unlikely to meet its primary test UK listed Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 2.1%. Jefferies raised the energy services a Read More
LONDON (Alliance News) - AstraZeneca PLC said Tuesday it has decided to discontinue trials of a new drug for Alzheimer's disease as the treatment is unlikely to meet its primary test UK listed Read More
